The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04722666
Recruitment Status : Terminated (Terminated by Novartis)
First Posted : January 25, 2021
Last Update Posted : April 22, 2024
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 26, 2023
Actual Study Completion Date : September 26, 2023